Skip to content

Randomized controlled study compararing efficacy and efficiency of diclofenac and paracetamol with chymotrypsin and diclofenac with paracetamol and betnesol and paracetamol as anti-inflammatory and analgesic agents following lower wisdom tooth extraction

Randomized controlled study compararing efficacy and efficiency of diclofenac and paracetamol with chymotrypsin and diclofenac with paracetamol and betamethasone and paracetamol as anti-inflammatory and analgesic agents following mandibular third molar surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/05/019340
Enrollment
60
Registered
2019-05-24
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: - Health Condition 2: R52- Pain, unspecified

Interventions

Intervention1: Not applicable: Routinely used Antiinflammatory and analgesic agent, diclofenac Intervention2: Acitryp-DP: 1 Tablet BID for 5 days Intervention3: Betnesol with Paracetamol: Betnesol 1Ta

Sponsors

Chhatrapal Raut
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Individual of consenting age falling in 18-40 age group. 2.individual needing mandibular wisdom molar extraction of class I level A( except distoangular type)

Exclusion criteria

Exclusion criteria: 1.individual with known H/O of Hyperacidity,renal disease, hypertension,ischemic heart disease,under antiplatelet and anticoagulant therapy, bronchial asthma, pregnant females. 2.patients with known allergy to any of the study drugs and amoxicillin. 3.mentally challenged patients.

Design outcomes

Primary

MeasureTime frame
To document side effects,to document onset and duration of pain relief post-operatively ,incidence of any recurrent infection .Timepoint: To document side effects,to document onset and duration of pain relief after 1,3 and 7th day post operatively,incidence of any recurrent infection

Secondary

MeasureTime frame
To document incidence of any recurrent infection after ceseation of medicationTimepoint: After ceseation of medication

Countries

India

Contacts

Public ContactChhatrapal Panchulal Raut

Nair hospital dental college, Mumbai.

mohandevidas@gmail.com8208422715

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026